Welcome to LookChem.com Sign In|Join Free
  • or
S-(2-chloroethyl)cysteine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

56674-34-1

Post Buying Request

56674-34-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

56674-34-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 56674-34-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,6,7 and 4 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 56674-34:
(7*5)+(6*6)+(5*6)+(4*7)+(3*4)+(2*3)+(1*4)=151
151 % 10 = 1
So 56674-34-1 is a valid CAS Registry Number.

56674-34-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name L-Cysteine, S-(2-chloroethyl)-, hydrochloride

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56674-34-1 SDS

56674-34-1Relevant academic research and scientific papers

Synthesis of Optically Active 1,4-Thiazane-3-carboxylic Acid via Optical Resolution by Preferential Crystallization of (RS)2-Amino-3-[(2-chloroethyl)sulfanyl]propanoic Acid Hydrochloride

Shiraiwa, Tadashi,Tadokoro, Kohya,Tanaka, Haruyuki,Nanba, Keiichiro,Yokono, Noriyoshi,Shibazaki, Katsuyoshi,Kubo, Motoki,Kurokawa, Hidemoto

, p. 2382 - 2387 (1998)

Optically active 1,4-thiazane-3-carboxylic acid [TCA] was synthesized from cysteine via optical resolution by preferential crystallization. The intermediate (RS)-2-amino-3-[(2-chloroethyl)sulfanyl]propanoic acid hydrochloride [(RS)-ACS-HCl] was found to exist as a conglomerate based on its melting point, solubility and IR spectrum. (RS)-ACS·HCl was optically resolved by preferential crystallization to yield (R)- and (S)-ACS·HCl. (R)- and (S)-ACS·HCl thus obtained were recrystallized from a mixture of hydrochloric acid and 2-propanol, taking account of the solubility of (RS)-ACS·HCl, efficiently yielding both enantiomers in optically pure forms. (R)- and (S)-TCA were then respectively synthesized by the cyclization of (R)- and (S)-ACS·HCI in ethanol in the presence of triethylamine.

MACROCYCLIC FUSED PYRRAZOLES AS MCL-1 INHIBITORS

-

Paragraph 0913, (2020/08/13)

Provided are compounds represented by Formula IA: (IA), and the pharmaceutically acceptable salts and solvates thereof, wherein R, R 1a, R 1b, L 1, L 2, L 3, X, A, B and C are as defined as set forth

Thiazine amide derivative thereof in the preparation of medicaments for preventing neurodegenerative diseases, the use of the

-

Paragraph 0021; 0028-0029, (2017/02/23)

The invention relates to a compound shown as the formula I, pharmaceutically acceptable salts of the compound, and/ or solvates and/ or hydrates of the compound. The invention also relates to a preparation method of the compound, a medicinal composition c

Thiazine Amide Derivative and Pharmaceutical Composition and Use Thereof

-

Paragraph 0062, (2015/07/27)

The present invention relates to a thiazine amide derivative and a pharmaceutical use thereof, and particularly to a compound of formula I (in the formula, variables are as described in the specification), a pharmaceutically acceptable salt, solvate or hy

THIAZINE AMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

-

Paragraph 0043, (2015/07/15)

The present invention relates to a thiazine amide derivative and a pharmaceutical use thereof, and particularly to a compound of formula I (in the formula, variables are as described in the specification), a pharmaceutically acceptable salt, solvate or hy

Substituted 6?membered n?heterocyclic compounds and their uses as neurological regulator

-

Page/Page column 6, (2008/06/13)

This invention relates to substituted 6-membered N-Herterocyclic neurotrophic compounds of formula (I) or pharmaceutically acceptable salts or hydrates thereof, wherein R1, R2, X, Y, and Z are as defined in the description; their pre

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 56674-34-1